A new system for platinum coils used to treat brain aneurysms has been backed by evidence from an 18-month study.

Published in The Lancet, the HydroCoil Endovascular Aneurysm Occlusion and Packing Study showed that the HydroCoil Embolic System for treating cerebral aneurysms reduced recurrence and retreatment rates and improved outcomes in patients when compared to bare platinum coils.

Manufactured by MicroVention-Terumo, the HydroCoil implant combines platinum with an expanding hydrogel polymer.

This provides the features of greater aneurysm volume filling with biologically inert material for natural tissue proliferation, according to the company.

Lead study author Dr Philip White, of Western General Hospital in Edinburgh, said the research shows that the non-invasive techniques for treating brain aneurysms are improving

"Hydrogel coated coils offer an improved treatment for ruptured aneurysms and coiling has a faster recovery than having to have brain surgery and come with less risk as well, which is great news for the thousands of people affected by this condition each year," he added.

Source:

Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil® Embolic System for Treatment of Cerebral Aneurysms (31/05/11) 

© Adfero Ltd